A031203: Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) With Commercially Supplied Sunitinib in Patients with Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma

CTO - 8565
Cancer - Genitourinary/ Prostate/ Kidney
  1. Males and females at least 18 years of age
  2. Histologic documentation: renal cell carcinoma with some component of clear cell histology; histologic documentation of metastatic disease is not required
Open
Tiffany Pearce